Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

Human respiratory syncytial virus (hRSV) is the most important viral agent of pediatric respiratory infections worldwide. The only specific treatment available today is a humanized monoclonal antibody (Palivizumab) directed against the F glycoprotein, administered prophylactically to children at ver...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Magro, Margarita, Mas, Vicente, Chappell, Keith, Vázquez, Mónica, Cano, Olga, Luque, Daniel, Terrón, María C., Melero, José A., Palomo, Concepción
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2012
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286924/
https://ncbi.nlm.nih.gov/pubmed/22323598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1115941109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados